Cover Image

Re: Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Theodoros P. Vassilakopoulos, Alexia Piperidou, Zois Mellios, Athanasios Liaskas, Maria K. Angelopoulou, Sotirios G. Papageorgiou
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Long‐Term Outcomes and Management Strategies With DA‐R‐EPOCH in Primary Mediastinal B‐Cell Lymphoma: Insights From a Single‐Center Experience
by: Robin Noel, et al.
Published: (2025)

346 | RITUXIMAB‐DOSE‐ADJUSTED EPOCH VERSUS RITUXIMAB‐CHOP IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA
by: T. Vassilakopoulos, et al.
Published: (2025)

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B‐Cell Lymphoma
by: Juliette Penichoux, et al.
Published: (2025)

Long‐Term Follow‐Up of Chidamide With Chemotherapy in Untreated Peripheral T‐Cell Lymphoma: One Single Center Real‐World Study in China
by: Jiajie He, et al.
Published: (2026)

Long‐Term Real‐World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results
by: Prokop Vodicka, et al.
Published: (2025)

CAR T‐Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real‐World Experiences From a Single Center on the Use of Radiotherapy
by: J.T. Jutzi, et al.
Published: (2025)

Routine Monitoring of CAR‐T‐Cells Expansion and Persistence in Patients With Aggressive Large B‐Cell Lymphoma by Flow Cytometry: A Single‐Center Experience
by: Alexandra Zduniak, et al.
Published: (2025)

Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT‐Lymphoma) of the Intestine: A Single Center Analysis
by: Oskar Steinbrecher, et al.
Published: (2024)

Clinical characteristics and outcome of early‐stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group
by: Evgenia Verrou, et al.
Published: (2024)

641 | OUTCOMES OF DOSE ADJUSTED R‐EPOCH IN ELDERLY PATIENTS: A RETROSPECTIVE STUDY
by: G. Kaleka, et al.
Published: (2025)

Breaking Traditions: Evaluating Single Fraction Radiation in Indolent Lymphoma
by: Hazim S. Ababneh, et al.
Published: (2024)

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center
by: Danai Dima, et al.
Published: (2025)

Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real‐Life Multicenter Experience. Results From the REDOT_MCL Study
by: Francesca Maria Quaglia, et al.
Published: (2026)

Clinical Impact of Osteolytic Bone Lesions in POEMS Syndrome: A Single‐Center Experience of 114 Patients
by: Tatsuzo Mishina, et al.
Published: (2025)

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance
by: Allison M. Bock, et al.
Published: (2024)

Toxicity and Tolerability of the OEPA/COPDAC Regimen in Children and Adolescents With Hodgkin Lymphoma: A Real‐World Experience
by: Hala Bekhit, et al.
Published: (2025)

Adaptation and Performance of the Self‐Report‐Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort
by: James R. Cerhan, et al.
Published: (2025)

75 | POPULATION‐WIDE INTRODUCTION OF DOSE‐ADJUSTED EPOCH‐R IN HIGH‐GRADE B‐CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS WITH DLBCL MORPHOLOGY
by: W. Alduaij, et al.
Published: (2025)

Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort Study
by: Pallawi Torka, et al.
Published: (2025)

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third‐Line CAR T
by: Inna Y. Gong, et al.
Published: (2026)

Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi‐Center Real‐Life Study
by: M. Picardi, et al.
Published: (2024)

RETRACTION: Burkitt Lymphoma Versus Diffuse Large B‐Cell Lymphoma: A Practical Approach
Published: (2026)

Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort Study
by: John L. Vaughn, et al.
Published: (2026)

Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients
by: A. Zduniak, et al.
Published: (2024)

Clinical Outcomes of CD7 CAR‐T Cell Therapy in Relapsed or Refractory T‐Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients
by: Jinyan Xiao, et al.
Published: (2025)

Peripheral T‐Cell Lymphoma: What's Next?
by: Sang Eun Yoon, et al.
Published: (2025)

Treatments and Outcomes of Newly Diagnosed CD5‐Positive Diffuse Large B‐Cell Lymphoma: A Multi‐Institutional Observational Study
by: Yuma Nato, et al.
Published: (2025)

678 | IMMUNE DYSREGULATION IN DIFFUSE LARGE B‐CELL LYMPHOMA/HIGH‐GRADE B‐CELL LYMPHOMA WITH MYC ALTERATIONS: COMPARATIVE ANALYSIS OF R‐CHOP VERSUS R‐DA‐EPOCH
by: N. De Lucas Torres, et al.
Published: (2025)

Outcome of Adult Lymphoblastic Lymphoma Patients Treated in the Real Life According to the Gimema LAL1913 Protocol: A Campus ALL Multicenter Study
by: M. Delia, et al.
Published: (2025)

Current Status of Revisions to the Lugano Classification in Lymphoma
Published: (2025)

Comprehensive Analysis of Single‐Cell and Bulk Transcriptomics Identified Regulatory T‐Cell Features as Predictors of Prognosis in Diffuse Large B‐Cell Lymphoma
by: Yaoli Cui, et al.
Published: (2025)

Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma
by: Rui Sun, et al.
Published: (2026)

Early Detection and Central Nervous System Prophylaxis in Patients With High‐Risk Features of Primary Lymphoma of the Female Genital Tract: The Key to Improved Prognosis
by: Bingyi Wang, et al.
Published: (2025)

A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B‐Cell Lymphoma of Immune‐Privileged Sites
by: Ganggang Wang, et al.
Published: (2025)

Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects
by: Emil Kumar, et al.
Published: (2025)

Lomustine, Etoposide and Cyclophosphamide as Conditioning for Auto‐HCT in Lymphomas
by: Rafaella Cabral Samico, et al.
Published: (2025)

Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Update on Biology and Treatment
by: Peter Borchmann, et al.
Published: (2025)

Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective
by: Giacomo Loseto, et al.
Published: (2025)

Indolent T‐Cell Lymphoma of the Gastrointestinal Tract Associated With Strongyloides Stercoralis Infection
by: Yue Zhao, et al.
Published: (2025)

Marginal Zone Lymphoma: Treatment Update With a Focus on Systemic Approaches
by: Sonali M. Smith
Published: (2025)